CAS: 7699-00-5; (R)-Ethyl 2-Hydroxypropanoate

该化合物是源于硝酸的一种手性酯,由于可生物降解性,低毒性和有利的环境特征,该化合物被广泛用作绿色溶剂.该化合物展示了树脂,纤维衍生物和油类的极佳的溶解性,使其在涂料,油墨和清洁配方中具有价值.它在各种条件下的高沸点和稳定性增强了其在工业应用中的效用.此外,其对应纯度(R-配置)在制药合成和农用化学生产中至关重要,因为立体选择性是不可或缺的.乙基(2R)-2-氢氧丙酸盐也用于食品和香味工业,因为其香味较轻.

结构式图片

相似化合物

687-47-8 2051-96-9 13650-70-9

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号617-35-6 丙酮酸乙酯 | CAS号64-17-5 乙醇 | CAS号18668-00-3 (R)-(+)-2-乙酰氧基丙酸 | CAS号4511-42-6 L-丙交酯 | CAS号10326-41-7 D-乳酸 | CAS号90246-32-5 Propanoic acid,... | CAS号687-47-8 (-)-乳酸乙酯 | CAS号13031-04-4 二氢-4,4-二甲基-2,3-呋喃二酮 | CAS号6342-56-9 丙酮醛缩二甲醇 | CAS号434-45-7 α,α,α-三氟苯乙酮 | CAS号4254-14-2 (|R|)-(-)-1,2-丙二醇 | CAS号18449-60-0 sec-butyl lactate | CAS号74497-15-7 (S)-2-氯丙酸乙酯 | CAS号10326-41-7 D-乳酸 | CAS号52298-33-6 1-ethoxycarbony...

合成工艺路线路线简述

  • 合成目标产物 (+)-Ethyl D-Lactate 主要起始原料 Ethanol And Propanoic Acid, 2-(Acetyloxy)-, (2R)-
  • (文献来源)合成步骤主要原料 Ethanol 和 Propanoic Acid, 2-(Acetyloxy)-, (2R)-
丙酮酸乙酯置于氢气,辛可尼丁体系中,用 溶剂黄146 作为反应溶剂,19.84 °C,6.5 Mpa 条件下,反应 0.03H,反应生成 D-乳酸乙酯
参考文献:增强限制在碳纳米管内进行不对称氢化的铂纳米催化剂的性能
标题:增强限制在碳纳米管内进行不对称氢化的铂纳米催化剂的性能
摘要:通过适当的通道:通过将用辛可尼定修饰的pt纳米颗粒限制在碳纳米管的通道内,制得了高活性和对映选择性的非均相不对称催化剂.当使用这种催化剂进行α-酮酸酯的不对称加氢时,可以实现高周转率(tof)和对映选择性.
DOI:10.1002/anie.201006870

海关参考信息

专利信息


专利号:US-8101779-B2
优先权日:2008-10-06
标题 :Enantioselective synthesis of (+) and (–)-2-[1-(2,6-dichlorophenoxy)-ethyl]-1,3-diazacyclopent-2-ene
发明人:CROOKS PETER A; VARTAK ASHISH PRAMOD
权利人:CROOKS PETER A; VARTAK ASHISH PRAMOD; UNIV KENTUCKY RES FOUND
摘要:Methods for the enantioselective synthesis of (+) and (−) lofexidine or 2-[1-(2,6)-dichlorophenoxy)-ethyl]-1,3-diazacyclopent-2-ene involve converting (+) or (−) 1-methyl-1-[2,6-dichlorophenoxy]ethanamide to an (+) or (−) imino-ether intermediate by electrophilic attack of the amide oxygen by a trimethoxonium ion and, without isolation, converting the (+) or (−) imino-ether intermediate to (+) or (−) 2-[1-(2,6-dichlorophenoxy)-ethyl]1,3-diazacyclopent-2-ene by adding ethylene diamine; and optionally converting the (+) or (−) 2-[1-(2,6-dichlorophenoxy)-ethyl]1,3-diazacyclopent-2-ene into a pharmaceutically acceptable acid addition salt thereof.

专利号:US-2009162290-A1
优先权日:2005-09-09
标 题 :Method for the synthesis of penta-pendant enantiomer-pure chelators and process for therapeutically active bioconjugates preparation by a covalent binding thereof
发明人:BENES IVAN; CIHELNIK SIMON; DROZ LADISLAV; SRAMEK MARTIN
权利人:THERAPHARM GMBH
摘要:The present invention provides a method for synthesis and binding methods of pentapendant enantiomer-pure chelators of formula (VII) wherein R 1 , R 2 , R 3 , R 4 are groups forming an adequate enantiomer of the chelator; and X 1 -X 5 , Y 1 -Y 5 , Z 1 -Z 5 each individually forming pendant chelating groups.

专利号:US-2024368343-A1
优先权日:2021-08-26
标题:Valorisation of d-lactic acid stream in the production process of l-polylactic acid
发明人:COSZACH PHILIPPE; VAN GANSBERGHE MARTIN
权利人:FUTERRO SA
摘要:The present invention discloses a valorization method of a flux containing undesired D-lactic acid (ester(s)) in the production process of L-polylactic acid, the production thereof comprising: oligomerisation (30) of a substantially pure L-lactic acid feed; cyclisation (40) of the lactic acid oligomers, thereby obtaining lactides and a first residual stream transferred, at least partially, to a transesterification (80) and a hydrolysis (90) step; lactide purification (50), thereby obtaining purified lactides comprising L-lactide and meso-lactide, a second and a third residual stream, wherein the second residual stream is transferred, at least partially, to the oligomerisation (30) step and the third residual stream is transferred, at least partially, to a transesterification (80) and a hydrolysis step (90); polymerisation (60) of the purified lactides into poly lactic acid; purification (70) of the poly lactic acid, thereby obtaining purified polylactic acid comprising substantially L-polylactic acid and unreacted L-lactide, unreacted meso-lactide and impurities transferred, at least partially, to the lactide purification step (50); transesterification (80) and hydrolysis (90) of the at least partially transferred first and third residual streams, thereby obtaining a fourth and a fifth residual stream which are used, at least partially, as a base for the synthesis of molecules insensitive to the optical isometry D or L of lactic acid (esters).

专利号:US-2004249147-A1
优先权日:2001-09-25
标题:Synthesis of key azole-antifungal intermediates
发明人:SATTIGERI JITENDRA; ARORA JASBIR SINGH; MALHOTRA SANJAY; VERMA ASHWANI KUMAR; SALMAN MOHAMMAD
摘要:Methods for producing azole compounds useful as intermediates for antifungal compounds and compositions including reaction of epoxy alcohols with reactants having active hydrogen attached to nitrogen, oxygen or sulfur in the presence of redox coupling agents. In some embodiments, a procedure known as a Mitsunobu reaction is utilized for the transformations.

专利号:US-11352311-B1
优先权日:2021-06-27
标题:Single-step stereospecific synthesis of (S)-2-chloropropionic acid alkyl ester
发明人:PATEL-FRAMROZE BOMI
权利人:PATEL FRAMROZE BOMI
摘要:Provided herein is a process to react optically pure alkyl lactates with thionyl chloride in the presence of a catalytic amount of a lewis base ionic liquid to produce optically pure chloropropionic acid alkyl esters.

专利号:WO-9967219-A1
优先权日:1998-06-22
标 题:Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
发明人:AUDIA JAMES E; PORTER WARREN J; THOMPSON RICHARD C; WILKIE STEPHEN C; STACK DOUGLAS R; SHI QING
权利人:ELAN PHARM INC; LILLY CO ELI; AUDIA JAMES E; PORTER WARREN J; THOMPSON RICHARD C; WILKIE STEPHEN C; STACK DOUGLAS R; SHI QING
摘要:Compounds of formula (I), wherein W is a cyclic group of the type (2); (3); Y is represented by the formula (II); these compounds inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
安徽启禾生物工程有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.qihebiochem.com
企业联系电话:13605116558👤
📞安徽启禾生物工程有限公司 ⚠️参考联系方式
联系人:夏继海
电话:13605116558
手机:13605116558

邮箱:xsy@qihebiochem.com
通信地址: 安徽省蚌埠市淮上区沫河口工业园区淝河北路591号
邮编:
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:安徽省蚌埠市淮上区沫河口工业园区淝河北路591号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
天津安浩生物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.ahpharmatech.com
企业联系电话:022-84840027👤
📞天津安浩生物科技有限公司 ⚠️参考联系方式
联系人:马经理
电话:022-84840027

传真:022-84840027
邮箱:sales@ahpharmatech.com
通信地址: 天津市东丽区四纬路10号2-201
邮编: 300300
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:天津市东丽区四纬路10号2-201
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
盐城鸿泰生物工程有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.hongtaibiochem.com
企业联系电话:0515-86111688;86221388;86098099👤
📞盐城鸿泰生物工程有限公司 ⚠️参考联系方式
联系人:徐鸿斌
电话:0515-86111688;86221388;86098099
手机:13905116218
传真:0515-86111033;86111603
邮箱:sales@hongtaibiochem.com
通信地址: 江苏省建湖县向阳西路271号
邮编: 224700
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江苏省建湖县向阳西路271号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

[参考文献]: Chiew Lin Yap, Et Al. Evaluation Of Solubility Of Polycyclic Aromatic Hydrocarbons In Ethyl Lactate/water Versus Ethanol/water Mixtures For Contaminated Soil Remediation Applications. J Environ Sci (China). 2012;24(6):1064-75.
[参考文献]: Elisabetta Ranucci, Et Al. End-Functionalised 1-Vinyl-2-Pyrrolidinone Oligomers Bearing Lactate Functions At One End. Macromol Biosci. 2004 Aug 9;4(8):706-13.
[参考文献]: Francisco Pérez-Mendoza, Et Al. Oxoester Oxidoreductase Activities In New Isolates Of Pichia Anomala From Apple, Grape And Cane Juices. Fems Yeast Res. 2005 Apr;5(6-7):685-90.
[参考文献]: Jiahua Li, Et Al. Ethyl Lactate-Edta Composite System Enhances The Remediation Of The Cadmium-Contaminated Soil By Autochthonous Willow (Salix X Aureo-Pendula Cl 'J1011') In The Lower Reaches Of The Yangtze River. J Hazard Mater. 2010 Sep 15;181(1-3):673-8.
[参考文献]: Jimmy T Liang, Et Al. Design Of Concise, Scalable Route To A Cholecystokinin 1 (Cck 1) Receptor Antagonist. J Org Chem. 2007 Oct 26;72(22):8243-50.

合成参考文献


摘要:Moody, T. S.; Mix, S.; Brown, G.; Beecher, D., Science of Synthesis: Biocatalysis in Organic Synthesis, (2015) 2, 429.
摘要:Parmeggiani, F.; Galman, J. L.; Montgomery, S. L.; Turner, N. J., Science of Synthesis, (2019) , 367.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知